<DOC>
	<DOCNO>NCT01952275</DOCNO>
	<brief_summary>This study investigate genetic architecture Neutrophil-Mediated Inflammatory Skin Diseases . After collect informed consent , patient ' clinical phenotype grade inclusion detailed case report form discovery cohort form base certainty diagnosis . The DNA patient discovery cohort analyze whole exome sequence identifies protein-coding genetic variant . Subsequently , statistical burden test go identify enrichment rare cod genetic variant patient affect Neutrophil-Mediated Inflammatory Skin Diseases . The ultimate goal reveal responsible gene ( ) may target clinical intervention .</brief_summary>
	<brief_title>Observational Study Genetic Architecture Neutrophil-Mediated Inflammatory Skin Diseases</brief_title>
	<detailed_description>Timeframe : - Collection DNA discovery cohort 05/2016 - Data analysis 12/2014 pyoderma gangrenosum , 12/2016 NMID - Report data presentation early 2015 PG , 2017 NMID</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Vasculitis</mesh_term>
	<mesh_term>Behcet Syndrome</mesh_term>
	<mesh_term>Pemphigus</mesh_term>
	<mesh_term>Epidermolysis Bullosa</mesh_term>
	<mesh_term>Erythema</mesh_term>
	<mesh_term>Hidradenitis</mesh_term>
	<mesh_term>Pyoderma Gangrenosum</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Pyoderma</mesh_term>
	<mesh_term>Familial Mediterranean Fever</mesh_term>
	<mesh_term>Dermatitis Herpetiformis</mesh_term>
	<mesh_term>Skin Diseases , Vesiculobullous</mesh_term>
	<mesh_term>Acute Generalized Exanthematous Pustulosis</mesh_term>
	<mesh_term>Linear IgA Bullous Dermatosis</mesh_term>
	<mesh_term>Sweet Syndrome</mesh_term>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Epidermolysis Bullosa Acquisita</mesh_term>
	<mesh_term>Vasculitis , Leukocytoclastic , Cutaneous</mesh_term>
	<criteria>Inclusion criterion : History NMID active disease . Informed consent . Exclusion criterion : No consent either part study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>